Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures

NCT00655551 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Epilepsies
Partial Onset Seizures

Interventions

DRUG: lacosamide
DRUG: lacosamide
DRUG: lacosamide

Sponsor

UCB BIOSCIENCES, Inc.